2019
The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis
Serfaty L, Jacobson I, Rockstroh J, Altice FL, Hwang P, Barr E, Robertson M, Haber B. The accuracy of baseline viral load for predicting the efficacy of elbasvir/grazoprevir in participants with hepatitis C virus genotype 1a infection: An integrated analysis. Journal Of Viral Hepatitis 2019, 26: 329-336. PMID: 30412325, DOI: 10.1111/jvh.13037.Peer-Reviewed Original ResearchMeSH KeywordsAmidesAntiviral AgentsBenzofuransCarbamatesCyclopropanesData Interpretation, StatisticalFemaleGenotypeHepacivirusHepatitis C, ChronicHumansImidazolesMalePredictive Value of TestsQuinoxalinesReproducibility of ResultsSensitivity and SpecificitySulfonamidesSustained Virologic ResponseViral LoadConceptsBaseline viral loadResistance-associated substitutionsNS5A resistance-associated substitutionsEBR/GZRElbasvir/grazoprevirGenotype 1a infectionViral loadNegative predictive valuePositive predictive valuePredictive valueBaseline NS5a resistance-associated substitutionsHepatitis C virus infectionPoor negative predictive valueEuropean treatment guidelinesC virus infectionSustained virologic responseHigh positive predictive valueEBR 50GT1a infectionVirologic failureVirologic responseTreatment guidelinesTreatment outcomesVirus infectionStratification factors
2014
Correlates of Having Never Been HIV Tested among Entrants to Substance Abuse Treatment Clinics: Empiric Findings from Real-World New England Settings
Chadwick JJ, Andrade LF, Altice FL, Petry NM. Correlates of Having Never Been HIV Tested among Entrants to Substance Abuse Treatment Clinics: Empiric Findings from Real-World New England Settings. Journal Of Psychoactive Drugs 2014, 46: 208-214. PMID: 25052879, PMCID: PMC4780256, DOI: 10.1080/02791072.2014.915363.Peer-Reviewed Original ResearchMeSH KeywordsAdultChi-Square DistributionDrug UsersEmploymentFemaleHealth Knowledge, Attitudes, PracticeHealth StatusHIV InfectionsHumansLogistic ModelsMaleMiddle AgedNew EnglandOdds RatioPatient Acceptance of Health CarePredictive Value of TestsRisk FactorsSerologic TestsSex FactorsSubstance Abuse Treatment CentersSubstance-Related DisordersConceptsSubstance abuse treatment patientsSubstance abuse treatment clinicsSubstance abuse patientsSubstance abuse treatmentHIV testingTreatment patientsMale genderTreatment clinicsAbuse patientsHIVPatientsMedical problemsAbuse treatmentRoutine testingClinicSignificant minorityReal-world evaluationEmpiric findingsTesting strategiesTreatmentTesting
2013
Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia
Margolis B, Al-Darraji HA, Wickersham JA, Kamarulzaman A, Altice FL. Prevalence of tuberculosis symptoms and latent tuberculous infection among prisoners in northeastern Malaysia. The International Journal Of Tuberculosis And Lung Disease 2013, 17: 1538-1544. PMID: 24200265, PMCID: PMC3913085, DOI: 10.5588/ijtld.13.0193.Peer-Reviewed Original ResearchConceptsLatent tuberculous infectionTuberculin skin testTB symptomsTuberculous infectionTwo-step tuberculin skin testPrevious incarcerationHuman immunodeficiency virus (HIV) infectionLower body mass indexReactive tuberculin skin testImmunodeficiency virus infectionBody mass indexRoutine screening procedureCross-sectional surveyCD4 statusRoutine tuberculosisTST reactivityTuberculosis symptomsActive tuberculosisLTBI prevalenceOnly significant correlateMass indexNortheastern MalaysiaSkin testVirus infectionHIVMethadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia
Wickersham JA, Zahari MM, Azar MM, Kamarulzaman A, Altice FL. Methadone dose at the time of release from prison significantly influences retention in treatment: Implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia. Drug And Alcohol Dependence 2013, 132: 378-382. PMID: 23414931, PMCID: PMC3718876, DOI: 10.1016/j.drugalcdep.2013.01.005.Peer-Reviewed Original ResearchConceptsMethadone maintenance treatmentMethadone doseKaplan-Meier survival analysisDose escalation procedureMethadone initiationThirty HIVMMT clinicsEvaluable participantsMaintenance treatmentOpioid dependenceMMT programSide effectsHigh dosesSurvival analysisHIVFirst weekPilot studyDoseMonthsTreatmentEscalation procedureDosesCravingParticipantsMonths of release